http://www.ncbi.nlm.nih.gov/pubmed/27557426

Thébaut A, Habes D, Gottrand F, Rivet C, Cohen J, Debray D, Jacquemin E, Gonzales E. J Pediatr Gastroenterol Nutr. 2016 Aug 24.

Abstract

BACKGROUNDS/AIM:

https://pubmed.ncbi.nlm.nih.gov/35626323/ cholestasis

Diagnostics (Basel). 2022 May 7;12(5):1169.
doi: 10.3390/diagnostics12051169.

Targeted-Capture Next-Generation Sequencing in Diagnosis Approach of Pediatric Cholestasis

Marion Almes 1 2 3, Anne Spraul 2 3 4, Mathias Ruiz 5, Muriel Girard 6, Bertrand Roquelaure 7, Nolwenn Laborde 8, Fréderic Gottrand 9, Anne Turquet 10, Thierry Lamireau 11, Alain Dabadie 12, Marjorie Bonneton 13, Alice Thebaut 1 2, Babara Rohmer 5, Florence Lacaille 6, Pierre Broué 8, Alexandre Fabre 7, Karine Mention-Mulliez 9, Jérôme Bouligand 3 14 15, Emmanuel Jacquemin 1 2 3, Emmanuel Gonzales 1 2 3

Abstract

https://pubmed.ncbi.nlm.nih.gov/37651067/ cholestasis

Review

Curr Gastroenterol Rep. 2023 Aug 31.
doi: 10.1007/s11894-023-00891-8.Online ahead of print.

Treatment of Cholestasis in Infants and Young Children
Nicole Heinz 1, Jennifer Vittorio 2

Abstract

Purpose of review: Cholestasis is characterized by a conjugated hyperbilirubinemia secondary to impaired bile synthesis, transport, or excretion from the liver. It is always pathologic and can be indicative of an underlying hepatobiliary, genetic, or metabolic disorder, several of which require timely diagnosis to ensure proper management and optimal outcomes. This review provides an overview of the evaluation of cholestasis with a focus on current and emerging treatment strategies.